The Division of Oncology 2 (DO2) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutic areas: Thoracic Head & neck, Neuro-oncology Rare cancers, Pediatric solid tumors.
Mailing Address
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Oncology 2 (DO2)
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2320
Fax: (301) 796-9849
Resources For You
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
